194 related articles for article (PubMed ID: 29570823)
1. A pediatric case of squamous cell cancer in situ in the setting of sclerodermatous graft-versus-host disease and voriconazole treatment.
Li AW; Lalor LE; Bellodi Schmidt F; Luu M
Pediatr Dermatol; 2018 May; 35(3):e165-e169. PubMed ID: 29570823
[TBL] [Abstract][Full Text] [Related]
2. High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole.
Ng W; Takahashi A; Muto Y; Yamazaki N
J Dermatol; 2017 Oct; 44(10):1152-1155. PubMed ID: 28470790
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole-associated phototoxic dermatoses and skin cancer.
Goyal RK
Expert Rev Anti Infect Ther; 2015; 13(12):1537-46. PubMed ID: 26488688
[TBL] [Abstract][Full Text] [Related]
4. An adolescent with a skin lesion. Squamous cell carcinoma of the skin secondary to voriconazole-induced photosensitivity.
Smart SE; Crosby T; Jeyakumar A
JAMA Otolaryngol Head Neck Surg; 2014 Oct; 140(10):979-80. PubMed ID: 25188536
[No Abstract] [Full Text] [Related]
5. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
Tolland JP; Devereux C; Jones FC; Bingham EA
Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
[TBL] [Abstract][Full Text] [Related]
6. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.
Cowen EW; Nguyen JC; Miller DD; McShane D; Arron ST; Prose NS; Turner ML; Fox LP
J Am Acad Dermatol; 2010 Jan; 62(1):31-37. PubMed ID: 19896749
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.
Wojenski DJ; Bartoo GT; Merten JA; Dierkhising RA; Barajas MR; El-Azhary RA; Wilson JW; Plevak MF; Hogan WJ; Litzow MR; Patnaik MM; Wolf RC; Hashmi SK
Transpl Infect Dis; 2015 Apr; 17(2):250-8. PubMed ID: 25661996
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment.
Wong JY; Kuzel P; Mullen J; Lien D; Mahmood M; Conrad C; Fiorillo L
Pediatr Transplant; 2014 Sep; 18(6):E200-7. PubMed ID: 25039541
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole phototoxicity in children: a retrospective review.
Sheu J; Hawryluk EB; Guo D; London WB; Huang JT
J Am Acad Dermatol; 2015 Feb; 72(2):314-20. PubMed ID: 25481710
[TBL] [Abstract][Full Text] [Related]
10. Phototoxicity and photocarcinogenesis associated with voriconazole.
Epaulard O; Leccia MT; Blanche S; Chosidow O; Mamzer-Bruneel MF; Ravaud P; Thiebaut A; Villier C; Lortholary O
Med Mal Infect; 2011 Dec; 41(12):639-45. PubMed ID: 22055586
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease.
Kim JB; Liakopoulou E; Watson JS
J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1235-8. PubMed ID: 17509955
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults.
Huang JT; Coughlin CC; Hawryluk EB; Hook K; Humphrey SR; Kruse L; Lawley L; Al-Sayegh H; London WB; Marghoob A; Phung TL; Pope E; Gerami P; Schmidt B; Robinson S; Bartenstein D; Bahrani E; Brahmbhatt M; Chen L; Haddock E; Mansour D; Nguyen J; Raisanen T; Tran G; Travis K; Wolner Z; Eichenfield LF
J Pediatr; 2019 Aug; 211():152-158. PubMed ID: 31103258
[TBL] [Abstract][Full Text] [Related]
13. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
Huu DL; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
Arthritis Rheum; 2013 Jun; 65(6):1624-35. PubMed ID: 23508350
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients.
Conlon JD; Dauenhauer M; Tonkovic-Capin V; Talano J; Margolis D; Drolet BA; Fairley JA
J Am Acad Dermatol; 2008 Mar; 58(3):484-7. PubMed ID: 18280346
[TBL] [Abstract][Full Text] [Related]
15. Oral precancerous and malignant lesions associated with graft-versus-host disease: report of 2 cases.
Abdelsayed RA; Sumner T; Allen CM; Treadway A; Ness GM; Penza SL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Jan; 93(1):75-80. PubMed ID: 11805779
[TBL] [Abstract][Full Text] [Related]
16. Recall of provision of sun protection measures to patients with cystic fibrosis being prescribed voriconazole.
Cunningham L; Moran M; Keating C; McKone E; Gallagher C; Lally A
Photodermatol Photoimmunol Photomed; 2015 Nov; 31(6):341-2. PubMed ID: 26139441
[No Abstract] [Full Text] [Related]
17. Epidermolysis bullosa acquisita-like reaction associated with penicillamine therapy for sclerodermatous graft-versus-host disease.
Cetkovská P; Pizinger K; Skálová A
J Am Acad Dermatol; 2003 Dec; 49(6):1157-9. PubMed ID: 14639407
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature.
Demarosi F; Soligo D; Lodi G; Moneghini L; Sardella A; Carrassi A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):63-9. PubMed ID: 15953918
[TBL] [Abstract][Full Text] [Related]
19. Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases.
Chosidow O; Bagot M; Vernant JP; Roujeau JC; Cordonnier C; Kuentz M; Wechsler J; André C; Touraine R; Revuz J
J Am Acad Dermatol; 1992 Jan; 26(1):49-55. PubMed ID: 1732335
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma in an immunosuppressed patient on voriconazole.
Carrascosa R; Solano-López GE; Vargas E; Fraga J
Actas Dermosifiliogr; 2014 May; 105(4):424-6. PubMed ID: 24007811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
